Approval · Notice of Compliance 25648 · 2021
TRESADERM: Notice of Compliance 25648
Issued April 13, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25648
- Date
- April 13, 2021
- Company
- Boehringer Ingelheim Animal Health Canada Inc.Burlington, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of drug substance manufacturer site - thiabendazole
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRESADERM | 00270512 | Cancelled Post Market |
Medicinal ingredients
- DEXAMETHASONE 1.1 MG per ML
- NEOMYCIN SULFATE 4 MG per ML
- THIABENDAZOLE 40 MG per ML